Tanox to Report First Quarter 2006 Financial Results, Host Conference Call for Investors May 2
April 10 2006 - 12:00PM
PR Newswire (US)
HOUSTON, April 10 /PRNewswire-FirstCall/ -- Tanox, Inc.
(NASDAQ:TNOX) will report its 2006 first quarter financial results
May 2, 2006. The announcement will be made prior to market open,
with a conference call for the financial community to follow at 10
a.m., EDT. Tanox President and Chief Executive Officer Danong Chen,
Ph.D. and Vice President of Finance Greg Guidroz will outline
results for the first quarter, provide an update on the company's
operations and lead a question-and-answer session. Live audio of
the conference call will be simultaneously webcast on the Internet.
The webcast will be accessible from the Tanox Web site at
http://www.tanox.com/ in the Investor Relations section. About
Tanox, Inc. Tanox is a biotechnology company specializing in the
discovery and development of monoclonal antibodies. The company
develops innovative biotherapeutics for the treatment of
immune-mediated diseases, inflammation, infectious disease and
cancer. Tanox's lead investigational therapy, TNX-355, is a
viral-entry inhibitor antibody to treat HIV/AIDS. TNX-355 has shown
significant antiviral activity in Phase 2 clinical testing. Tanox's
first- approved drug, Xolair(R) (omalizumab), is the first antibody
approved to treat moderate-to-severe confirmed allergic asthma.
Xolair was developed in collaboration with Genentech, Inc. and
Novartis Pharma AG and is approved for marketing in the United
States, Canada and major European countries. Tanox is based in
Houston and has a manufacturing facility in San Diego. Additional
corporate information is available at http://www.tanox.com/ .
http://www.newscom.com/cgi-bin/prnh/20050207/TNOXLOGO DATASOURCE:
Tanox, Inc. CONTACT: Steve Sievert of Tanox, Inc., +1-713-578-4211,
or Web site: http://www.tanox.com/
Copyright
Tanox (NASDAQ:TNOX)
Historical Stock Chart
From May 2024 to Jun 2024
Tanox (NASDAQ:TNOX)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Tanox (MM) (NASDAQ): 0 recent articles
More Tanox (MM) News Articles